Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas
- PMID: 22925496
- DOI: 10.1016/j.critrevonc.2012.08.002
Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas
Abstract
High-grade glioma patients receiving concomitant chemoradiotherapy with temozolomide 75mg/m(2) during six to seven weeks or dose-dense temozolomide regimens especially in combination with chronic use of corticosteroids have a high risk for developing Pneumocystis jirovecii pneumonia. In this review, we define risk groups and propose a guideline for prophylaxis using risk stratification.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources